Nicholas W Baxter
CIK 1312326 · President and CEO · last filed 2025-05-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
30
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXXW) Delisted | Director | 11,000 | $0.00 | $13 | $0 | 10 | 2025-05-16 |
Recent Filings · Page 3 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-12-31 | — | Buy (P) | +176,000 | $21.1K | |
| 2014-11-03 | — | Buy (P) | +24,000 | $2.9K | |
| 2012-06-12 | — | Mixed | — | $0 | |
| 2012-04-20 | — | Other (J) | +5,000,000 | $250.0K | |
| 2011-06-21 | — | Mixed | — | $0 | |
| 2011-03-15 | — | Sell (S) | −1,000,000 | -$55.0K | |
| 2009-11-23 | — | Buy (P) | +2,500,000 | $125.0K | |
| 2008-05-27 | — | Sell (S) | −2,000,000 | -$100.0K | |
| 2007-08-21 | — | Buy (P) | +73,364 | $18.3K | |
| 2007-04-24 | — | Grant (A) | — | $0 |
Showing 21–30 of 30
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.